stella
beta
SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer — Stella
Recruiting
Back to Radiation Therapy trials
Trial locations
(2 sites)
China
Peking University First Hospital, Beijing, Beijing Municipality
Peking University Third Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov